OWC Pharmaceutical Research Corp Appoints Dr. Stanley Hirsch as its Active Chairman

PETACH TIKVA, Israel, July 25, 2017 /PRNewswire/ —

OWC Pharmaceutical Research Corp. (OTCQB: OWCP), (“OWC” or the “Company”), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced the appointment of Dr. Stanley Hirsch as its active chairman of the board of directors.

     (Logo: http://mma.prnewswire.com/media/458036/OWC_Logo.jpg )

Dr. Stanley Hirsch, age 59, has had extensive scientific, executive and board level experience for more than the past 25 years in private and publicly listed companies in biopharmaceutical and agricultural biotech industries, among others, including direct experience in raising capital and leading MA activity together with multi-cultural management skills, having managed companies in Israel, Brazil, UK, China and the United States.

Mr. Mordechai Bignitz Chief Executive Officer, commented on the appointment, “I am proud and honored to have Dr. Hirsch agreeing to join OWCP and assume the role of active

... read more at: http://markets.businessinsider.com/news/stocks/OWC-Pharmaceutical-Research-Corp-Appoints-Dr-Stanley-Hirsch-as-its-Active-Chairman-1002201471